Tri Chemical LaboratoriesTri Chemical Laboratories Inc.4369東証プライム化学FY ending Jan 2026, consolidated, J-GAAP
Tri Chemical Laboratories brought in ¥18.9B in revenue.
Out of every ¥100 of sales, about ¥28 is left as operating profit.
Revenue changed +68.1% from the prior year, operating profit +169.8%.
Revenue +68.1% · profit +169.8%, calculated from disclosed figures.
Operating leverage: 2.49× (profit growth ÷ revenue growth)
FY ending Jan 2024 → FY ending Jan 2025
FY ending Jan 2024 → FY ending Jan 2025
For every ¥100 Tri Chemical Laboratories sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第48期(2025/02/01-2026/01/31)
EDINET (FSA Japan)
有価証券報告書-第47期(2024/02/01-2025/01/31)
EDINET (FSA Japan)
有価証券報告書-第46期(2023/02/01-2024/01/31)
EDINET (FSA Japan)
有価証券報告書-第45期(2022/02/01-2023/01/31)
EDINET (FSA Japan)
有価証券報告書-第44期(令和3年2月1日-令和4年1月31日)
EDINET (FSA Japan)
有価証券報告書-第43期(令和2年2月1日-令和3年1月31日)
Extracted from XBRL: 48 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.